Super-extended (D3) lymphadenectomy in advanced gastric cancer

European Journal of Surgical Oncology

Volumn 36, Issue 5, 2010, Pages 439-446

  Roviello, F ^a   Pedrazzani, C ^a   Marrelli, D ^a   Di Leo, A ^b   Caruso, S ^a   Giacopuzzi, S ^b   Corso, G ^a   de Manzoni, G ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

D3 Lymphadenectomy; Gastric cancer; Prognosis; Surgery

Indexed keywords

ABDOMINAL ABSCESS; ABDOMINAL BLEEDING; ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS BLEEDING; ANASTOMOSIS LEAKAGE; ARTICLE; BILE DUCT FISTULA; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DELAYED STOMACH EMPTYING; DUODENAL STUMP LEAK; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INCIDENCE; LUNG DISEASE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHORREA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OVERALL SURVIVAL; PANCREAS FISTULA; PANCREATITIS; PARAAORTIC LYMPH NODE; PARALYTIC ILEUS; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; SURGICAL MORTALITY;

ADULT; AGED; AGED, 80 AND OVER; AORTA; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS;

EID: 77952421435     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.03.008     Document Type: Article

References (30)

1. Maruyama K., Okabayashi K., and Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11 (1987) 418-425
2. Bonenkamp J.J., Hermans M., Sasako M., and van de Velde C.J.H. Extended lymph-node dissection for gastric cancer. N Engl J Med 340 (1999) 908-914
3. Cuschieri A., Weeden S., Fielding J., et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79 (1999) 1522-1530
4. Wu C.W., Hsiung C.A., Lo S.S., et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7 (2006) 309-315
5. Siewert J.R., Bottcher K., Roder J.D., et al. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 80 (1993) 1015-1018
6. Roukos D.H., Lorenz M., and Encke A. Evidence of survival benefit of extended (D2) lymphadenectomy in Western patients with gastric cancer based on a new concept: a prospective long-term follow-up study. Surgery 123 (1997) 573-578
7. Roviello F., Marrelli D., Morgagni P., et al., Italian Research Group for Gastric Cancer. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol 9 (2002) 894-900
8. de Manzoni G., Verlato G., Guglielmi A., et al. Prognostic significance of lymph node dissection in gastric cancer. Br J Surg 83 (1996) 1604-1607
9. Marrelli D., De Stefano A., de Manzoni G., et al. Italian research group for gastric cancer. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg 241 (2005) 247-255
10. Japanese Gastric Cancer Association (JGCA). The new Japanese classification of gastric carcinoma. 2nd English edition. Gastric Cancer 1 (1998) 1-15
11. Marrelli D., Pedrazzani C., Neri A., et al. Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors. Ann Surg Oncol 14 (2007) 25-33
12. Pedrazzani C., de Manzoni G., Marrelli D., et al. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg 134 (2007) 378-385
13. McCulloch P., Nita M.E., Kazi H., and Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach (Cochrane Review). The cochrane library (2003), John Wiley & Sons, Chichester, UK Issue 4
14. Wu C.W., Hsiung C.A., Lo S.S., et al. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 91 (2004) 283-287
15. Roviello F., Marrelli D., de Manzoni G., et al., Italian Research Group for Gastric Cancer. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 90 (2001) 1113-1119
16. Hartgrink H.H., van de Velde C.J., Putter H., et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22 (2004) 2069-2077
17. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
18. Marubini E., Bozzetti F., Miceli R., et al., The Italian Gastrointestinal Tumour Study Group. Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications. Eur J Surg Oncol 28 (2002) 406-412
19. Maruyama K., Gunven P., Okabayashi K., et al. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 210 (1989) 596-602
20. Bunt A.M.G., Hermans J., Smit V.T.H., et al. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 13 (1995) 19-25
21. Harrison L.E., Karpeh M.S., and Brennan M.F. Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J Gastrointest Surg 2 (1998) 126-131
22. de Manzoni G., Verlato G., Roviello F., et al., Italian Research Group for Gastric Cancer. The new TNM classification of lymph node metastasis minimizes stage migration problems in gastric cancer patients. Br J Cancer 87 (2002) 171-174
23. Kitamura K., Nishida S., Yamamoto K., et al. Lymph node metastasis in gastric cancer in the upper third of the stomach. Surgical treatment on the basis of the anatomical distribution of positive node. Hepatogastroenterology 45 (1998) 281-285
24. Kunisaki C., Shimada H., Yamaoka H., et al. Indication for paraaortic lymph node dissection in gastric cancer patients with paraortic lymph node involvement. Hepatogastroenterology 47 (2000) 586-589
25. Maeta M., Yamashiro H., Saito H., et al. A prospective pilot study of extended (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy. Surgery 125 (1999) 325-331
26. Degiuli M., Sasako M., Calgaro M., et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 30 (2004) 303-308
27. Sano T., Sasako M., Yamamoto S., et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan clinical oncology group study 9501. J Clin Oncol 22 (2004) 2767-2773
28. Kulig J., Popiela T., Kolodziejczyk P., Sierzega M., Szczepanik A., and Polish Gastric Cancer Study Group. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 193 (2007) 10-15
29. Pacelli F., Doglietto G.B., Bellantone R., et al. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg 80 (1993) 1153-1156
30. Sasako M., Sano T., Yamamoto S., et al., Japan Clinical Oncology Group (JCOG). D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359 (2008) 453-462